論文 - 詳細
| RRC ID | 67065 |
|---|---|
| 著者 | Zhang S, Guo F, Yu M, Yang X, Yao Z, Li Q, Wei Z, Feng K, Zeng P, Zhao D, Li X, Zhu Y, Miao QR, Iwakiri Y, Chen Y, Han J, Duan Y. |
| タイトル | Reduced Nogo expression inhibits diet-induced metabolic disorders by regulating ChREBP and insulin activity. |
| ジャーナル | J Hepatol |
| Abstract |
BACKGROUND & AIMS:Chronic overconsumption of a high-carbohydrate diet leads to steatosis and its associated metabolic disorder and, eventually, to non-alcoholic fatty liver disease. Carbohydrate-responsive element binding protein (ChREBP) and insulin regulate de novo lipogenesis from glucose. Herein, we studied the effect of reticulon-4 (Nogo) expression on diet-induced metabolic disorders in mice. METHODS:Nogo-deficient (Nogo-/-) and littermate control [wild-type (WT)] mice were fed a high-glucose or high-fructose diet (HGD/HFrD) to induce metabolic disorders. The effects of Nogo small interfering (si) RNA (siRNA) on HFrD-induced metabolic disorders were investigated in C57BL/6J mice. RESULTS:HGD/HFrD induced steatosis and its associated metabolic disorders in WT mice by activating ChREBP and impairing insulin sensitivity. They also activated Nogo-B expression, which in turn inhibited insulin activity. In response to HGD/HFrD feeding, Nogo deficiency enhanced insulin sensitivity and energy metabolism to reduce the expression of ChREBP and lipogenic molecules, activated AMP-activated catalytic subunit α, peroxisome proliferator activated receptor α and fibroblast growth factor 21, and reduced endoplasmic reticulum (ER) stress and inflammation, thereby blocking HGD/HFrD-induced hepatic lipid accumulation, insulin resistance and other metabolic disorders. Injection of Nogo siRNA protected C57BL/6J mice against HFrD-induced metabolic disorders by ameliorating insulin sensitivity, ChREBP activity, ER stress and inflammation. CONCLUSIONS:Our study identified Nogo as an important mediator of insulin sensitivity and ChREBP activity. Reduction of Nogo expression is a potential strategy for the treatment of high-carbohydrate diet-induced metabolic complications. LAY SUMMARY:Nogo deficiency blocks high-carbohydrate diet-induced glucose intolerance and insulin resistance, while increasing glucose/lipid utilisation and energy expenditure. Thus, reduction of Nogo expression protects against high-carbohydrate diet-induced body-weight gain, hepatic lipid accumulation and the associated metabolic disorders, indicating that approaches inhibiting Nogo expression can be applied for the treatment of diseases associated with metabolic disorders. |
| 巻・号 | 73(6) |
| ページ | 1482-1495 |
| 公開日 | 2020-12-1 |
| DOI | 10.1016/j.jhep.2020.07.034 |
| PII | S0168-8278(20)30487-6 |
| PMID | 32738448 |
| MeSH | Animals Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / metabolism* Dietary Carbohydrates / metabolism* Drug Discovery Energy Metabolism Glucose Intolerance / metabolism* Insulin / metabolism Insulin Resistance Lipogenesis / physiology Mice Mice, Inbred C57BL Nogo Proteins / deficiency Nogo Proteins / genetics* Non-alcoholic Fatty Liver Disease / metabolism* RNA, Small Interfering / metabolism |
| IF | 20.582 |
| リソース情報 | |
| ヒト・動物細胞 | HuH-7(RCB1366) |